Search Results - "Nappi, L"

Refine Results
  1. 1

    Pathophysiology of hypoxic–ischemic encephalopathy: a review of the past and a view on the future by Greco, P., Nencini, G., Piva, I., Scioscia, M., Volta, C. A., Spadaro, S., Neri, M., Bonaccorsi, G., Greco, F., Cocco, I., Sorrentino, F., D’Antonio, F., Nappi, L.

    Published in Acta neurologica Belgica (01-04-2020)
    “…Hypoxic–ischemic encephalopathy, also referred as HIE, is a type of brain injury or damage that is caused by a lack of oxygen to the brain during neonatal…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Outcome of twin–twin transfusion syndrome according to Quintero stage of disease: systematic review and meta‐analysis by Di Mascio, D., Khalil, A., D'Amico, A., Buca, D., Benedetti Panici, P., Flacco, M. E., Manzoli, L., Liberati, M., Nappi, L., Berghella, V., D'Antonio, F.

    Published in Ultrasound in obstetrics & gynecology (01-12-2020)
    “…ABSTRACT Objectives To report the outcome of pregnancies complicated by twin–twin transfusion syndrome (TTTS) according to Quintero stage. Methods MEDLINE,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models by D'Amato, V, Rosa, R, D'Amato, C, Formisano, L, Marciano, R, Nappi, L, Raimondo, L, Di Mauro, C, Servetto, A, Fusciello, C, Veneziani, B M, De Placido, S, Bianco, R

    Published in British journal of cancer (10-06-2014)
    “…Background: Cetuximab is the only targeted agent approved for the treatment of head and neck squamous cell carcinomas (HNSCC), but low response rates and…”
    Get full text
    Journal Article
  7. 7

    Current and Emerging Uses of Statins in Clinical Therapeutics: A Review by Davies, Jonathan T., Delfino, Spencer F., Feinberg, Chad E., Johnson, Meghan F., Nappi, Veronica L., Olinger, Joshua T., Schwab, Anthony P., Swanson, Hollie I.

    Published in Lipid Insights (2016)
    “…Statins, a class of cholesterol-lowering medications that inhibit 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, are commonly administered to treat…”
    Get full text
    Journal Article Book Review
  8. 8

    NT >99th centile and cystic hygroma: Which diagnosis, which management and outcome by Vasciaveo, L., Mastricci, A. L., De Lucia, G., Zanzarelli, E., De Feo, V., Giansiracusa, E., Di Biase, S., Nappi, L.

    Published in Journal of clinical ultrasound (01-10-2024)
    “…Objectives To evaluate the prevalence of chromosomal anomalies in fetuses affected by increased nuchal translucency(iNT >99Th centile), cystic hygroma (CH) and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells by D’Amato, C, Rosa, R, Marciano, R, D’Amato, V, Formisano, L, Nappi, L, Raimondo, L, Di Mauro, C, Servetto, A, Fulciniti, F, Cipolletta, A, Bianco, C, Ciardiello, F, Veneziani, B M, De Placido, S, Bianco, R

    Published in British journal of cancer (09-09-2014)
    “…Background: Multiple lines of evidence support that the Hedgehog (Hh) signalling has a role in the maintenance and progression of different human cancers…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Three-dimensional echocardiographic evaluation of the right ventricle in patients with uncomplicated systemic lupus erythematosus by Buonauro, A, Sorrentino, R, Esposito, R, Nappi, L, Lobasso, A, Santoro, C, Rivellese, F, Sellitto, V, Rossi, F W, Liccardo, B, Tufano, A, Galderisi, M, Paulis, A de

    Published in Lupus (01-04-2019)
    “…Our aim was to identify subclinical right ventricular (RV) alterations in systemic lupus erythematosus (SLE) by combining standard and three-dimensional…”
    Get full text
    Journal Article
  14. 14

    Primary borderline paraovarian serous tumor in pregnancy: case report and review of the literature by F. Sorrentino, F. Boncristiano, F. Greco, A. D’Aloia, P. Di Gioia, L. Nappi

    “…There are few reports of pregnancy complicated by a primary borderline paraovarian tumor. A 37-year-old woman after four pregnancies was found to have an…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer by Rosa, R, Damiano, V, Nappi, L, Formisano, L, Massari, F, Scarpa, A, Martignoni, G, Bianco, R, Tortora, G

    Published in British journal of cancer (06-08-2013)
    “…Background: We aimed to study key signalling proteins involved in angiogenesis and proliferation on the response to inhibitors of tyrosine kinases and…”
    Get full text
    Journal Article
  17. 17

    Bilateral salpingo-oophorectomy and adhesiolysis with single port access laparoscopy and use of diode laser in a BRCA carrier by Angioni, S, Pontis, A, Sorrentino, F, Nappi, L

    “…Herein the authors report the first case of prophylactic bilateral salpingo-ovariectomy (BSO) in single port access laparoscopy (SPAL) with use of diode laser…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr. bipolar electrode by Bettocchi, S., Ceci, O., Di Venere, R., Pansini, M.V., Pellegrino, A., Marello, F., Nappi, L.

    Published in Human reproduction (Oxford) (01-09-2002)
    “…BACKGROUND: The aim of this study was to evaluate treatment efficacy and patient acceptability of a new bipolar probe used during office hysteroscopic…”
    Get full text
    Journal Article
  20. 20

    Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis by Damiano, V, Rosa, R, Formisano, L, Nappi, L, Gelardi, T, Marciano, R, Cozzolino, I, Troncone, G, Agrawal, S, Veneziani, B M, De Placido, S, Bianco, R, Tortora, G

    Published in British journal of cancer (30-04-2013)
    “…Background: Targeting the mammalian target of rapamycin by everolimus is a successful approach for renal cell carcinoma (RCC) therapy. The Toll-like receptor 9…”
    Get full text
    Journal Article